banner

Category Archives: CLSA Wire

FAST & Fellows Round-Up

Read the latest in FAST and Fellows news: FAST graduate GigaGen (Spring 2015) has entered into a strategic partnership with Trianni, a company that has developed novel mouse strains genetically engineered to express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody therapeutics through The Trianni Mouse platform. Click HERE for more … Continue reading FAST & Fellows Round-Up

Swallowing A Biologic Drug?

Original article posted on BioTech Primer SURVIVING THE STOMACH IS KEY Over the past two decades, biologic drugs — drugs composed of proteins produced by living cells — have become the safest, most effective top sellers within the pharmaceutical industry. Approved to treat a variety of diseases including rheumatoid arthritis, diabetes, multiple sclerosis, Crohn’s disease, … Continue reading Swallowing A Biologic Drug?

OCTANe Announces Inaugural Report Detailing Impact On Orange County’s Tech Ecosystem

OCTANe, Orange County’s life sciences and technology accelerator organization, today announced the release of its inaugural OCTANe Impact Report, a comprehensive paper detailing the current state of Orange County’s tech and med-tech environment. The report includes OCTANe’s insights for spurring economic growth in the region while providing a comprehensive look at its progressive service portfolio. … Continue reading OCTANe Announces Inaugural Report Detailing Impact On Orange County’s Tech Ecosystem

San Diego Life Sciences Company Tackles Debilitating Disorder

Imagine not being able to always control the movements of your body.  Not being able to control your hand or foot movements.  Imagine smacking your lips and blinking excessively or not being able to control your tongue.  Would this impact your social interactions?  Your work?  Your relationships?  Your self-confidence?  These uncontrollable symptoms are experienced daily … Continue reading San Diego Life Sciences Company Tackles Debilitating Disorder

CLSA Welcomes New Members and Explores Proposed Budget Cuts to NIH Funding

Sara Radcliffe President & CEO CLSA – California Life Sciences Association  March 23, 2017 Welcoming New Members Please join me in welcoming the 18 new CLSA members who joined us in the last month: Aline, Ambryx Inc., GraphWear Technologies Inc., Henlix Inc., Inflammatix Inc., Innocart Inc., Innovation Properties Group Inc., Leerink Partners, Maverick Therapeutics Inc., MEI Pharma, Resilience … Continue reading CLSA Welcomes New Members and Explores Proposed Budget Cuts to NIH Funding